tiprankstipranks

12222022 top21 - New Portfolio

613D487C

12222022 top21
Individual Investor
Ranked #414,067 out of 769,654 TipRanks' Investors
Success Rate
46%
175 out of 384
profitable transactions
Average Return
4.71%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 4.34%
6-Month Return▼ 7.03%
12-Month Return▲ 38.31%
YTD Return▲ 13.46%
Total Return▲ 37.57%

Best Trade

Opened at
Closed at
Gain▲ 418.52%

Bio

Financial advisor for 45 years.?

Performance

31.73%0-31.73%
▼ 12.40%
▼ 4.03%
▼ 14.11%
Apr 2024
▲ 11.46%
▲ 5.06%
▲ 3.26%
May 2024
▼ 2.25%
▲ 3.53%
▼ 9.69%
Jun 2024
▲ 25.72%
▲ 1.21%
▲ 9.31%
Jul 2024
▼ 4.22%
▲ 2.34%
▼ 4.61%
Aug 2024
▲ 7.82%
▲ 2.10%
▲ 1.05%
Sep 2024
▲ 5.70%
▼ 0.89%
▲ 0.17%
Oct 2024
▲ 31.73%
▲ 4.73%
▼ 2.93%
Nov 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 12.40%▼ 4.03%▼ 14.11%
▲ 11.46%▲ 5.06%▲ 3.26%
▼ 2.25%▲ 3.53%▼ 9.69%
▲ 25.72%▲ 1.21%▲ 9.31%
▼ 4.22%▲ 2.34%▼ 4.61%
▲ 7.82%▲ 2.10%▲ 1.05%
▲ 5.70%▼ 0.89%▲ 0.17%
▲ 31.73%▲ 4.73%▼ 2.93%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Landos Biopharma
▲ 259.97%
2
Close
May 23, 2024
Permrock Royalty
▲ 3.77%
2
Close
Mar 05, 2024
Autolus Therapeutics
1.59%
▲ 24.98%
4
Open
Feb 27, 2024
Editas Medicine
1.59%
▼ 49.71%
4
Open
Feb 27, 2024
Can-Fite BioPharma
▼ 20.51%
6
Close
Feb 27, 2024
Gritstone bio
▼ 9.80%
4
Close
Feb 27, 2024
Dianthus Therapeutics
▼ 19.76%
4
Close
Feb 27, 2024
Stoke Therapeutics
1.59%
▲ 3.51%
5
Open
Feb 27, 2024
Sutro Biopharma
▼ 19.61%
6
Close
Feb 27, 2024
Syros Pharmaceuticals
▲ 65.72%
4
Close
Feb 27, 2024
Jasper Therapeutics
▲ 1.03%
3
Close
Feb 27, 2024
NGM Biopharmaceuticals
▲ 2.11%
4
Close
Feb 27, 2024
Mersana Therapeutics
1.59%
▼ 5.36%
4
Open
Feb 27, 2024
Intellia Therapeutics
▼ 16.61%
3
Close
Feb 27, 2024
Xeris Pharmaceuticals
▲ 29.40%
6
Close
Feb 27, 2024
Sonnet BioTherapeutics Holdings
1.59%
▼ 30.94%
3
Open
Feb 27, 2024
Akoya Biosciences
1.59%
▼ 54.52%
4
Open
Feb 27, 2024
Heron Therapeutics
▲ 66.06%
2
Close
Feb 27, 2024
Syndax Pharmaceuticals
▲ 18.50%
3
Close
Feb 27, 2024
Akero Therapeutics
▲ 17.04%
3
Close
Feb 27, 2024